Elevance Health, Inc.

ELV NYSE CIK: 0001156039

Company Information

Industry Hospital & Medical Service Plans
SIC Code 6324
Entity Type operating
SEC Category Large accelerated filer
State of Incorporation IN
Business Address 220 VIRGINIA AVENUE, INDIANAPOLIS, IN, 46204
Mailing Address 220 VIRGINIA AVENUE, INDIANAPOLIS, IN, 46204
Phone 8003311476
Fiscal Year End 1231
EIN 352145715

Financial Overview

FY2025 FY

$199.13B
Revenue
$5.99B
Net Income
$77.47B
Total Liabilities
$9.49B
Cash & Equivalents
$25.81
EPS

Recent SEC Filings

Form Type Date Filed Document
DEF 14A Definitive proxy statement March 27, 2026 View on SEC
SCHEDULE 13G/A Passive ownership amendment March 26, 2026 View on SEC
4 Insider stock transaction report March 23, 2026 View on SEC
8-K Current report of material events March 10, 2026 View on SEC
4 Insider stock transaction report March 9, 2026 View on SEC
4 Insider stock transaction report March 6, 2026 View on SEC
4 Insider stock transaction report March 4, 2026 View on SEC
4 Insider stock transaction report March 4, 2026 View on SEC
4 Insider stock transaction report March 4, 2026 View on SEC
4 Insider stock transaction report March 4, 2026 View on SEC

Annual Reports

10-K February 6, 2026
  • Demonstrated strong financial performance with a healthy bottom line.
  • Maintained a strong balance sheet and robust operating cash flow, ensuring ample liquidity for strategic investments and shareholder returns.
View Analysis

Material Events

8-K Strategy Change March 10, 2026
High Impact
  • Elevance Health acquired CareConnect Solutions, a technology company specializing in advanced care management platforms, enhancing clinical capabilities and operational efficiencies.
  • The acquisition strengthens Elevance's competitive position in the value-based care landscape and aligns with its long-term strategy for integrated health solutions.
View Analysis
8-K Legal Issue March 2, 2026
High Impact
  • Elevance Health faces proposed CMS sanctions impacting its critical Medicare Advantage business.
  • Sanctions include suspending new enrollments and restricting marketing activities for MA-PD plans.
View Analysis

Insider Trading

SELL 3 insiders 3 recent transactions
View Full Insider Trading Profile

Related Companies

Companies in the same industry (SIC: 6324)

Investor Resources

Learn more about SEC filings and how to research public companies.

Important Disclaimer

This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.